James Green

CytomX heads to key investor conferences with its PROBODY platform. Can promising clinical data and big pharma partnerships overcome recent financial hurdles?

Teva wins key EU approvals for denosumab biosimilars, challenging Amgen's dominance and promising lower costs for osteoporosis and cancer care.

As cyber threats escalate, MSIG USA appoints a new chief to lead its North American expansion. A deep dive into the strategy to capture a booming market.

Facing a cash crunch, Tempest raised up to $8.35M. The deal dilutes shares but buys time for its Phase 3-ready cancer drug and a new CAR-T focus.

A new market report reveals the growing role of a humble seaweed derivative in advanced wound care, drug delivery, and regenerative medicine.

A strong debut in a key client survey shows Hexaware is rewriting the rules in Germany's demanding IT market, balancing innovation with competitive pricing.

An Ottawa study shows an AI scribe cut therapist documentation by 66%, boosting well-being and pointing to a scalable solution for clinician burnout.

Facing a critical labor shortage, the U.S. Virgin Islands is leveraging its massive reconstruction boom to reward nations that reject risky passport schemes.

As fraud volumes stabilize, a new era of AI-powered attacks emerges. Discover the "Sophistication Shift" and the invisible tech battle reshaping security.

Rocket Lab's record-setting 19th launch of 2025 will carry a JAXA tech-demo satellite, a mission highlighting market leadership and US-Japan space diplomacy.

A new service merges branding and interior design, transforming physical spaces from a cost center into a strategic asset for growth and market impact.

A 148,000-acre forest famed by artists is now a carbon credit powerhouse, using LiDAR and market savvy to redefine conservation and green finance.

The European car wash market is set to hit $4.3B, driven by touchless tech and eco-trends. Discover how deep data is the new competitive edge.

Manitoba is launching a digital health initiative with $2.1M in federal funds to tackle life-threatening language barriers for its rural Francophone population.

Echo IQ's AI tool, EchoSolv HF, shows breakthrough accuracy in a major Mayo Clinic study, paving the way for FDA clearance to tackle a $60B crisis.

A new journal from a key standards body reveals how Generative AI is quietly moving into critical industries, automating negotiations, and managing infrastructure.

A pivotal Phase 3 trial expands to Europe, offering the first non-surgical hope for patients with FAP, a rare disorder causing near-certain cancer.

Aldebaran Resources reveals a robust economic study for its Altar copper mine, but the news is eclipsed by a key partner's surprise withdrawal.

A junior explorer's stunning high-grade discovery in the Canadian Arctic promises a new source of critical metals, but can it overcome the North's immense hurdles?

In its first major move post-IPO, Atmus acquires Koch Filter, targeting high-growth industrial air filtration for data centers and healthcare.